Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14228016 | 0.87 | CXCR4 (0.80) | CXCR4KCNH2 | |
| SCHEMBL4936270 | 0.87 | CXCR4 (0.90) | CXCR4KCNH2 | |
| SCHEMBL4936686 | 0.86 | CXCR4 (1.00) | CXCR4KCNH2 | |
| SCHEMBL4940042 | 0.86 | CXCR4 (0.83) | CXCR4KCNH2 | |
| SCHEMBL4932260 | 0.86 | CXCR4 (1.00) | CXCR4KCNH2 | |
| SCHEMBL14275068 | 0.86 | CXCR4 (0.65) | CXCR4KCNH2 | |
| SCHEMBL4938164 | 0.86 | CXCR4 (0.77) | CXCR4KCNH2 | |
| SCHEMBL4938814 | 0.86 | CXCR4 (0.83) | CXCR4KCNH2 | |
| SCHEMBL4939469 | 0.86 | CXCR4 (1.00) | CXCR4KCNH2 | |
| SCHEMBL4935692 | 0.85 | CXCR4 (0.76) | CXCR4KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238244-A1 | USE OF A COMPOUND SUCH AS PLERIXAFOR FOR TREATING A VIRAL PULMONARY DISEASE | 4LIVING BIOTECH (FR) | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238244-A1 | USE OF A COMPOUND SUCH AS PLERIXAFOR FOR TREATING A VIRAL PULMONARY DISEASE | CCL11, CXCR1, REN | CXCR4 12/4885KCNH2 1724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.